Chemotherapy-induced peripheral neuropathy (cipn)

Authors

  • Sandra Ponte Centro Hospitalar de Lisboa Ocidental – Hospital de S. Francisco Xavier, Lisboa
  • M.ª Teresa Récio Centro Hospitalar de Lisboa Ocidental – Hospital de S. Francisco Xavier, Lisboa

Keywords:

Neuropathy, Chemotherapy

Abstract

Chemotherapy-Induced Peripheral Neuropathy (NPIQ) is a dysfunction of neurons due to the administration of neurotoxic cytotoxic. We aim to promote the early diagnosis of NPIQ through the application of an instrument for neurotoxicity evaluation and its nursing record in Day Hospital. The study deals with an analysis of the records made in the electronic clinical process in a day hospital session in the first 2016. Our sample consisted of 146 patients receiving oxaliplatin, paclitaxel and bortezomib. The results show that there are gaps in the registry regarding the absence of symptomatology, but when this information is recorded it is observed that the predominant symptomatology is paresthesia’s of grade 1 in the hands and grade 2 in the feet, being the pain a frequent signal. Nurses must develop knowledge, skills, and abilities that allow them to adopt measures to promote the management and adherence to the therapeutic regime, the training for the self-care of the person and their functional re-adaptation. They also must improve the registration of their interventions for better continuity and quality of care.

Downloads

Download data is not yet available.

References

Associação Enfermagem Oncológica Portuguesa. Neuropatia Periférica. Traduzido e adaptado de EONS – PEP`s. Portugal, 2015

American Oncology Society. Peripheral neuropathy caused by chemotherapy. Estados Unidos: American Cancer Society, 2015.

ARGYROU, A; et al. – Chemotherapy-induced peripheral neurotoxicity (CIPN): na update. Critical Reviews in Oncology/hematology, Boca Raton. V82, n1, p.51-77, april 2012.

CAROZZI, V; et al. – Chemotherapy-induced peripheral neurophaty: what do we know about mechanisms? Neuroscience letters, amsterdam. V2, n.596, p.90-107, june 2015.

DAWN, L.; et al – Preventation and management of chemotherapy-induced peripheral neurophaty in survivours of adult cancers: american society of clinical oncology clinical practice guideline. Journal of Clinical oncology. New York. V.32,p.1941-1967, april 2014

MERKIES, I.; et al - Advances in diagnostics and outcome measures in peripheral neuropathies. Neuroscience Letters, Limerick, v. 596, p. 3-13, june 2015.

SERETNY, M.; et al. Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: a systematic review and meta-analysis. Pain, Amsterdam, v. 155, n. 12, p. 2461–2470, December 2014.

SIMÃO, D.; et al. Neuropatia periférica induzida por quimioterapia: revisão para a prática clínica. Revista Dor, São Paulo, 2015.

Published

2017-07-25

How to Cite

1.
Ponte S, Récio MT. Chemotherapy-induced peripheral neuropathy (cipn). Onco.News [Internet]. 2017 Jul. 25 [cited 2024 Nov. 23];(34):26-9. Available from: https://onco.news/index.php/journal/article/view/89

Issue

Section

Original Articles